Profile
Ms. Helene Depui Ekdal was previously employed as a Senior Director by AstraZeneca AB and a Director-Clinical Development by Egetis Therapeutics AB.
She received her graduate degree from Chalmers University of Technology and an MBA from Handelshögskolan i Göteborg.
Former positions of Helene Depui Ekdal
| Companies | Position | End |
|---|---|---|
| EGETIS THERAPEUTICS AB | Chief Tech/Sci/R&D Officer | 2023-05-31 |
AstraZeneca AB
 AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Corporate Officer/Principal | 2018-12-31 |
Training of Helene Depui Ekdal
| Chalmers University of Technology | Graduate Degree |
| Handelshögskolan i Göteborg | Masters Business Admin |
Experiences
Positions held
Connections
1st degree connections
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Listed companies | 1 |
|---|---|
| EGETIS THERAPEUTICS AB | Health Technology |
| Private companies | 1 |
|---|---|
AstraZeneca AB
AstraZeneca AB Miscellaneous Commercial ServicesCommercial Services AstraZeneca AB engages in biopharmaceutical business. It provides treatment of diseases in cardiovascular and metabolic diseases, cancer, respiratory, inflammation, and autoimmunity. The firm offers operations in the areas of infection, neuroscience, and stomach and intestinal diseases. The company was founded in 1999 and is headquartered in Sodertalje, Sweden. | Commercial Services |
- Stock Market
- Insiders
- Helene Depui Ekdal
